Severity
Critical
FDA Drug recall · Reported May 18, 2022
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
Fagron, Inc recalled SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-112… - a critical-severity action.
SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-112… was recalled by Fagron, Inc in May 18, 2022. Reason: Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.. Check the official notice for the remedy. Verify recall #D-0856-2022 with the FDA Drug before acting.
The recall
Fagron, Inc issued this critical-severity FDA Drug recall-Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli..
Sourced from official FDA Drug enforcement records. Verify recall #D-0856-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0856-2022) was formally reported on May 18, 2022, with the manufacturer initiating the action on March 4, 2022. It is classified under Critical severity (Class I), with a current status of Completed. Fagron, Inc is listed as the recalling firm, operating out of Saint Paul, MN. Federal records list the affected scope as a) 559 bottles and b) 243 bottles.
The documented reason for this recall is: Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli. Distribution data in the federal record shows the product reached: Nationwide USA and Puerto Rico, Canada, Columbia, France. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
a) 559 bottles and b) 243 bottles
Related Recalls
6
5 from same agency
SyrSpend SF Suspending Base, Cherry Flavored, packaged in a) 500mL bottles (NDC 51552-1123-5) and b) 4L bottles (NDC 51552-1123-9), Rx Only, Manufactured for Fagron, Inc., St. Paul, MN 55120.
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Completed |
| Recall number | D-0856-2022 |
| Date reported | May 18, 2022 |
| Date initiated | March 4, 2022 |
| Recalling firm | Fagron, Inc |
| Firm location | Saint Paul, MN |
| Affected scope | a) 559 bottles and b) 243 bottles |
| Distribution | Nationwide USA and Puerto Rico, Canada, Columbia, France |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 18, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.